Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ivermectin + metronidazole
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Ivermectin + metronidazole is a topical combination medication that works through dual mechanisms to treat inflammatory skin conditions, particularly rosacea and Demodex-related disorders. Ivermectin functions as both an anti-inflammatory agent and an antiparasitic that targets Demodex mites, which have been implicated in rosacea pathophysiology. Metronidazole reduces reactive oxygen species, decreases oxidative tissue injury by inhibiting neutrophil-generated cytokines, and provides additional anti-inflammatory and antimicrobial effects. Clinical studies have shown this combination to be more effective than either agent alone, with superior efficacy in reducing inflammatory lesions, eradicating Demodex mites, and improving overall skin condition. The combination has demonstrated complete Demodex eradication, improved tear film parameters in patients with meibomian gland dysfunction, and reduced ocular symptoms.
- Other names
- Ivermectin/metronidazole topicalIvermectin-metronidazole gel
02
Targets
DNAGluCl (Glutamate-gated chloride channel)
Beyond the preview
Go deeper on ivermectin + metronidazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ivermectin + metronidazole.